US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class I · High risk Terminated

Easy Care First Aid Class A ANSI 25 Person

Reason Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.

GFA Production Xiamen Co. Ltd. D-0250-2023
Class I · High risk Terminated

Easy Care First Aid 10 Person 2009 ANSI

Reason Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.

GFA Production Xiamen Co. Ltd. D-0249-2023
Class I · High risk Terminated

Easy Care First Aid 25 Person 2009 ANSI

Reason Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.

GFA Production Xiamen Co. Ltd. D-0248-2023
Class I · High risk Terminated

Adventure First Aid 1.5

Reason Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.

GFA Production Xiamen Co. Ltd. D-0247-2023
Class I · High risk Terminated

Adventure First Aid 1.0

Reason Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.

GFA Production Xiamen Co. Ltd. D-0246-2023
Class I · High risk Terminated

Adventure Marine 150

Reason Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.

GFA Production Xiamen Co. Ltd. D-0245-2023
Class I · High risk Terminated

Easy Care first aid Burn Cream

Reason Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.

GFA Production Xiamen Co. Ltd. D-0244-2023
Class II · Moderate risk Terminated

Voriconazole 10mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0243-2023
Class II · Moderate risk Terminated

Vitamin D3-Aqueous- 10

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0242-2023
Class II · Moderate risk Terminated

Vancomycin Fortified 10mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0241-2023
Class II · Moderate risk Terminated

Tobramycin Fortified 15mg/Ml Oph Solution

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0240-2023
Class II · Moderate risk Terminated

Testosterone 3%

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0238-2023
Class II · Moderate risk Terminated

Tacrolimus 0.03% Oph Solution Tacrolimus 0.1%

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0237-2023
Class II · Moderate risk Terminated

Semaglutide 0.5mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0236-2023
Class II · Moderate risk Terminated

Scopolamine Hydrobromide 0.25% Oph Solution

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0235-2023
Class II · Moderate risk Terminated

Prostaglandin

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0234-2023
Class II · Moderate risk Terminated

Progesterone-Gs Oil- 100mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0233-2023
Class II · Moderate risk Terminated

Polyhexamethylene Biguanide 0.2mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0232-2023
Class II · Moderate risk Terminated

Polidocanol 50mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0231-2023
Class II · Moderate risk Terminated

Phosphatidylcholine/Deoxycholic Acid

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0230-2023
Class II · Moderate risk Terminated

Phenol 10%

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0229-2023
Class II · Moderate risk Terminated

Pe1/Papav/Phen 20mcg/30mg/2mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0228-2023
Class II · Moderate risk Terminated

Papaverine/Phentolamine 30mg/0.5mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0226-2023